+148.5%
MRNA vs SSNC
+7.3%
+141.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | SSNC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -0.5% | +1.3% | +1.2% |
| 7D | -8.2% | -6.7% | -1.5% | -2.6% |
| 30D | +125.6% | -0.8% | +126.4% | +130.8% |
| 3M | +197.1% | +16.1% | +181.0% | +196.9% |
| 6M | +148.5% | +7.9% | +140.5% | +161.3% |
| All | +148.5% | +7.3% | +141.2% | +161.3% |
Cumulative growth
Daily Returns
Daily percentage return beside SSNC.
Daily Out/Under-Performance
Portfolio return minus SSNC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SSNC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded SSNC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling